- Federal agenciesReduces federal Medicaid reimbursements for listed gender‑affirming services for minors, potentially lowering federal e…
- StatesShifts policy decision and potential financial responsibility for these services toward States and private payers.
- Potential benefitAffirms parental consent requirement for the bill’s medical exceptions, strengthening parental control over minor’s car…
Do No Harm in Medicaid Act
Referred to the House Committee on Energy and Commerce.
The bill amends Title XIX of the Social Security Act to prohibit Federal Medicaid funding for specified gender transition procedures and related drugs for individuals under 18. It lists specific surgeries, implants, puberty blockers, and supraphysiologic hormone dosing that would not be federally reimbursable, while carving out exceptions for treatment of precocious puberty and for medically verifiable disorders of sex development or urgent life-threatening physical conditions.
Progressives emphasize discrimination and harm to transgender minors
Relative to its intended legislative type, this bill is a well-specified substantive amendment to Medicaid reimbursement law: it precisely identifies statutory targets, enumerates covered and excluded procedures and drugs, and integrates its changes directly into Title XIX.
The bill amends Title XIX of the Social Security Act to prohibit Federal Medicaid funding for specified gender transition procedures and related drugs for individuals under 18.
It lists specific surgeries, implants, puberty blockers, and supraphysiologic hormone dosing that would not be federally reimbursable, while carving out exceptions for treatment of precocious puberty and for medically verifiable disorders of sex development or urgent life-threatening physical conditions.
The amendment also defines “sex” in biologically reproductive terms for the statute’s purposes.
Narrow but ideologically polarizing federal restriction on Medicaid coverage; easier in a receptive House but faces major Senate, legal, and implementation hurdles.
Relative to its intended legislative type, this bill is a well-specified substantive amendment to Medicaid reimbursement law: it precisely identifies statutory targets, enumerates covered and excluded procedures and drugs, and integrates its changes directly into Title XIX. It is strongest on mechanism specificity and integration with existing law.
Progressives emphasize discrimination and harm to transgender minors
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenReduces access to Medicaid‑covered gender‑affirming care for minors, increasing out‑of‑pocket costs for families.
- Potential burdenMay increase unmet mental‑health needs and downstream health costs if care is delayed or foregone.
- StatesCreates administrative burdens as State Medicaid programs revise coverage rules, claims processing, and compliance syst…
Why the argument around this bill splits.
Progressives emphasize discrimination and harm to transgender minors
Likely strongly opposed.
They would view the ban as a restriction on access to medically recommended care for transgender minors and as a discriminatory limitation tied to gender identity.
They would note the bill limits Medicaid coverage rather than clinical practice decisions and could exacerbate health disparities.
Mixed/uncertain.
A centrist would see legitimate questions about using federal funds for controversial, irreversible treatments on minors but would be concerned about blunt federal prohibitions that could block medically necessary care.
They would prioritize clearer medical-necessity standards, narrow scope, and minimizing cost-shifting to states.
Likely strongly supportive.
They would view the bill as preventing taxpayer dollars from funding gender-transition procedures for minors and protecting children from irreversible interventions.
The statutory sex definitions and enumerated procedural list reinforce the bill’s limiting intent.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow but ideologically polarizing federal restriction on Medicaid coverage; easier in a receptive House but faces major Senate, legal, and implementation hurdles.
- Absent CBO score and fiscal estimate
- Unknown level of House committee and floor coalition support
Recent votes on the bill.
The House passed this bill. It now goes to the other chamber, and eventually to the President for signature.
What is a final passage?Hide explanation
The final vote on whether the bill becomes law (pending the other chamber and the President).
The attempt to send the bill back to committee failed. The bill continues moving forward.
What is a send back to committee?Hide explanation
A motion to recommit sends a bill back to committee, often as a last-ditch attempt to stop it.
Go deeper than the headline read.
Progressives emphasize discrimination and harm to transgender minors
Narrow but ideologically polarizing federal restriction on Medicaid coverage; easier in a receptive House but faces major Senate, legal, an…
Relative to its intended legislative type, this bill is a well-specified substantive amendment to Medicaid reimbursement law: it precisely identifies statutory targets, enumerates covered and excluded procedures and dru…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.